Lung cancer screening offers an important opportunity for instituting cardiovascular disease risk assessment in all participants, regardless of the presence of LDCT-detected CAC.
LCS offers an important opportunity for instituting CVD risk assessment in all LCS participants irrespective of the presence of LDCT-detected CAC. Further studies are needed to determine whether CAC could enhance uptake and adherence to primary preventative strategies.
Ruparel et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: